Search - tctmd.com

Displaying 581 - 600 of 626

Sort: Relevancy | Date

News Daily News

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

L.A. McKeown

March 12, 2012

News Industry News

OrbusNeich’s Genous™ Stent Is a Safe and Effective Option in Patients with ST-Segment Elevation Myocardial Infarction (STEMI)

March 06, 2012

News Daily News

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

L.A. McKeown

March 06, 2012

News Daily News

Documento Examina las Diferencias que existen entre Estudios Observacionales y Aleatorizados del Cierre del PFO

L.A. McKeown

March 06, 2012

News Daily News

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

Jason Kahn

March 05, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

Presentation ISET 2012

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Presenter: Gregg W. Stone

January 15, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

December 13, 2011

News Daily News

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Yael L. Maxwell

December 12, 2011

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Conference News

Hybrid Coronary Revascularization Associated with Fast Recovery

November 07, 2011

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Industry News

Virmani's crystal ball: Transcatheter valves

November 06, 2011

News Industry News

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

November 06, 2011

News Industry News

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

November 04, 2011

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

Hope Renewed for Novel Anticoagulant Use in ACS

Caitlin E. Cox

October 05, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

Advertisement

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

OrbusNeich’s Genous™ Stent Is a Safe and Effective Option in Patients with ST-Segment Elevation Myocardial Infarction (STEMI)

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

Documento Examina las Diferencias que existen entre Estudios Observacionales y Aleatorizados del Cierre del PFO

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Ongoing Trials Explore Potential Benefits of Transradial PCI

Hybrid Coronary Revascularization Associated with Fast Recovery

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

Virmani's crystal ball: Transcatheter valves

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

Hope Renewed for Novel Anticoagulant Use in ACS

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content